1. FDA safety communication: update on serious complications associated with transvaginal placement of surgical mesh for pelvic organ prolapse;US Food and Drug Administration (FDA),2011
2. Recalls and safety alerts. surgical mesh – complications associated with transvaginal implantation for the treatment of stress urinary incontinence and pelvic organ prolapse – notice to hospitals;Government of Canada,2014
3. Results of review into urogynaecological surgical mesh implants;Therapeutic Goods Administration, Department of Health, Australian Government,2014
4. Women left “scarred” after vaginal mesh implants;Connolly,2017